Evolus (EOLS) Free Cash Flow (2017 - 2026)
Evolus' (EOLS) quarterly Free Cash Flow came in at -$10.0 million in Q1 2026, up 37.53% YoY from -$7.2 million in Q1 2025, and down 182.08% on a QoQ basis from $12.1 million in Q4 2025.
Evolus (EOLS) Free Cash Flow (2017 - 2026) Analysis & Trends
Evolus (EOLS) has 10 years of Free Cash Flow data on file, last reported at -$10.0 million in Q1 2026.
- Quarterly Free Cash Flow rose 37.53% year-over-year to -$10.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$41.3 million (down 68.18% YoY) and the FY2025 annual result came in at -$47.3 million, down 142.8% from the prior year.
- Free Cash Flow retreated to -$10.0 million in Q1 2026, from $12.1 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $12.1 million in Q4 2025 to a low of -$38.2 million in Q1 2022.
- A 5-year average of -$11.7 million and a median of -$10.9 million in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow slumped 358.06% — and 2024, when it soared 561.12%.
- Tracing EOLS's Free Cash Flow over 5 years: stood at -$9.6 million in 2022, then surged by 106.86% to $661000.0 in 2023, then soared by 561.12% to $4.4 million in 2024, then jumped by 177.8% to $12.1 million in 2025, then sank by 182.08% to -$10.0 million in 2026.
- The last three Free Cash Flow figures came in at -$10.0 million (Q1 2026), $12.1 million (Q4 2025), and -$15.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Evolus | 552.49 Mn | 507.32 Mn | 57.18 Mn | -4.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.04 Mn |
| Jun 30, 2026 | -4.04 Mn |
| Mar 31, 2026 | -9.96 Mn |
| Mar 31, 2026 | -9.96 Mn |
| Dec 31, 2025 | 12.14 Mn |
| Dec 31, 2025 | 12.14 Mn |
| Sep 30, 2025 | -15.87 Mn |
| Sep 30, 2025 | -15.87 Mn |
| Jun 30, 2025 | -27.59 Mn |
| Jun 30, 2025 | -27.59 Mn |
| Mar 31, 2025 | -15.95 Mn |
| Mar 31, 2025 | -15.95 Mn |
| Dec 31, 2024 | 4.37 Mn |
| Dec 31, 2024 | 4.37 Mn |
| Sep 30, 2024 | -5.43 Mn |
| Sep 30, 2024 | -5.43 Mn |
| Jun 30, 2024 | -7.54 Mn |
| Jun 30, 2024 | -7.54 Mn |
| Mar 31, 2024 | -10.87 Mn |
| Mar 31, 2024 | -10.87 Mn |